Search results
Author(s):
Shawna D Nesbitt
Added:
3 years ago
Epidemiology
Hypertension is both more common and more destructive in African-Americans than in other ethnic groups. According to the 2005–2006 National Health and Nutrition Examination Survey (NHANES) data, the current prevalence of hypertension in African-Americans is 39.1%, which is well above non-Hispanic whites at 28.5%. While awareness and treatment rates are similar between African…
View more
Author(s):
Gavin L Noble
,
Gary V Heller
Added:
3 years ago
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated. The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion. The national focus on cardiovascular research, diagnosis and…
View more
Author(s):
Gavin L Noble
,
Gary V Heller
Added:
3 years ago
Introduction
Coronary artery disease (CAD) is the leading cause of death in the US in both men and women, and in all ethnic groups that have been evaluated.1 The American College of Cardiology estimated the 1998 annual costs (direct and indirect) of CAD in the US to be US$368.4 billion, compared with cumulative cancer costs of US$189 billion.2 The scope of this problem is expanding as the…
View more
Author(s):
Ana Mola
,
Carmen Perez-Terzic
,
Randal Thomas
,
et al
Added:
3 years ago
The changing population landscape in the US has impacted the many levels of the US healthcare system. It is estimated that, by 2050, minority populations together will comprise approximately 50% of the total population.1 This demographic shift has prompted policy makers, scientists, researchers, educators, and healthcare providers to draft a series of national health initiatives to define,…
View more
Gender Disparities in PAD
Author(s):
Andrea Martinez
,
Jingwen Huang
,
Arash Harzand
Added:
1 month ago
Article
Author(s):
Ariana Traub
,
Apoorva Sharma
,
Maria Carolina Gongora
Added:
1 month ago
Author(s):
David Lanfear
Added:
2 years ago
In this video, Professor David Lanfear (Henry Ford Hospital, Detroit, MI, US) discusses a subgroup analysis of GALACTIC-HF which aimed to evaluate the effect of omecamtiv mecarbil in black patients with heart failure (HF) with reduced ejection fraction (HFrEF). Originally presented at HFSA 2021, the additional results suggest that the outcomes in black patients treated with this drug are similar…
View more
Author(s):
Deepak Padmanabhan
,
Ameesh Isath
,
Bernard J Gersh
Added:
3 years ago
Endovascular techniques for renal denervation (RDN) as a treatment for hypertension were initially highly encouraging with reductions in blood pressure (BP) in the range of 30 mmHg.1 However, these high expectations received a major setback following the unexpected results of the sham-controlled Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3) trial. This promising…
View more
Jenni Perri
Job title: Clinical Fellow
Author
Mary Costantino
Job title: Interventional Radiologist
Author